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ABSTRACT 
Objectives: The incidence of thyroid cancer is increasing in several countries. The main aim of 
this study was to find and describe province-specific estimates of incidence in males and females 
by age groups for thyroid cancer. 
Methodology: The data used in this study were collected from a cancer registry that was 
established by Health Deputy of Golestan province for a period of one year (2004), in different 
age groups. Thyroid cancer data was identified and collected through the eighteen Pathology 
Laboratory centers (where males and female populations is referred) in Golestan province. 
Results: A total of 348 females and 409 males cases with cancer representing all sites were 
identified during the study period. It included seventeen females and five male thyroid cancer 
patients. In female’s thyroid cancer, there were twelve papillary carcinoma (70.6%), two 
medullary carcinoma, one carcinoma anaplastic and one carcinoma (5.9%). In male’s, there were 
two papillary carcinoma (40%) and one follicular carcinoma. The incidence of thyroid cancer in 
70-79 age groups for females and males was the highest and lowest in age group 10-19 years’ in 
females and 30-39 years in males. 
Conclusion: The incidence of thyroid cancer is higher in females when compared with males as 
per this one year study. However since this is just one year data, it needs to be studied further to 
confirm these findings. 
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INTRODUCTION 
Cancer is becoming a leading cause of death 
in many countries of the world. In 1984, 5.8 
million new cancer cases was reported from 
developing countries.1 Many studies demon­
strate that cancer incidence among different 
people are heterogeneous. Thyroid carcinoma 
(TC) is a relatively rare tumor, but it represents 
the most frequent form of cancer of the endo­
crine glands. It represents 1% of human 
neoplasias and its annual incidence is estimated 
worldwide from 0.5 to 10/100,000 subjects in 
the world population.2 
The annual incidence of thyroid cancer 
varies considerably in different registries. High 
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incidence rates in Hawaii, Iceland and Israel 
have been known for some years. For the most 
recent data, female Hawaiians, Icelanders, 
Israeli Jews and Austrian Tyrolese have rates 
in the range of 8.5 – 19.4 per 100,000.3 The 
highest incidence occurs in Iceland, followed 
by Austria and Finland, while relatively low 
incidence characterizes the UK, Netherlands 
and Denmark.4 While the incidence of many 
head and neck cancers in the United States is 
decreasing,5 a number of registries have 
reported that the incidence of thyroid cancer 
is increasing.6-11 Some investigators have attrib­
uted the increase to environmental radiation,9 
while others have found no obvious source.7 
The incidence of thyroid cancer is increasing 
in some European countries, USA and 
Canada.12-14 
The main aim of this study was to find out 
and describe province-specific estimates of in­
cidence by age groups for thyroid cancer in the 
year 2004. 
METHODOLOGY 
The data used in this study was collected from 
a cancer registry that was established by Health 
Deputy of Golestan province in Iran for a 
period of one year (2004). Golestan province is 
located in north of Iran (South East of Caspian 
Sea). The collected data included population 
distribution by gender and age, divided into 
ten-year intervals. The age distribution was 
collected according to the following age strata: 
0-9, 10-19, 20-29, 30-39, 40-49, 50-59, 60-69, 
70-79 and 80-85 above. Different cancer data 
was identified and collected through the 18 
Pathology Laboratory centers (where males 
and female populations is referred). Using a 
structured questionnaire, trained personnel 
conducted personal interviews to collect 
information on thyroid cancer in the Golestan 
province. 
The newly diagnosed cases were detected by 
histopathological, cytological examinations. 
These were then sent to the Cancer Registry 
Office of the province and to the registry unit 
in the Health Deputy. Age-specific rates, 
annual age-adjusted rates (ASRs) per 100,000 
person-years were calculated using the direct 
methods of standardization to the world popu­
lation. The data was summarized in a data 
sheet and coded using the ICD-10. The data 
were recorded at different levels to ensure cor­
rect registration. This has been done by 
iarccrgtools-203 software. 
RESULTS 
A total of 348 females and 409 males cases 
with cancer from all sites were identified dur­
ing the study period. The cases detected in­
cluded seventeen (4.9%) females and five 
(1.2%) males thyroid cancer. In females’ thy­
roid cancer, there were twelve papillary carci­
noma (70.6%), two medullary carcinoma 
(17.6%), one carcinoma anaplastic (5.9%) and 
one carcinoma (5.9%). In male’s thyroid can­
cer, there were two papillary carcinoma (40%) 
and one follicular carcinoma (20%). The inci­
dence for papillary carcinoma was the highest 
in Golestan province in females 70.6% and in 
males 40%. 
The results from Golestan province Cancer 
Registry for the year 2004 show that cancer of 
thyroid is the sixth and fifth common cancer 
in women and men respectively. The Annual 
Specific Rate (ASR) is 2.65 and 0.75 per 100,000 
in females and males respectively. The highest 
thyroid cancer incidence among females and 
males in Golestan province was in age group 
70-79 (ASR: 37.19/100,000) and (ASR: 11.83/ 
100,000) respectively. The thyroid cancer 
incidence according to age specific is shown 
in Table-I. 
DISCUSSION 
The results of this study show that the inci­
dence of thyroid cancer in Golestan province 
has increased over the past few years if com­
pared with an earlier study.15 Recent rise in 
incidence, especially among younger women, 
suggest that overall incidence may continue to 
increase for the foreseeable future. Golestan 
province has relatively low prevalence of 
thyroid cancer when compared with other 
countries.16 For example, age-standardized 
incidence rates are higher in males and females 
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Table-I: Thyroid cancer incidence among males and female in Golestan province in 2004 
Male Female 
Ages persons Incidence persons  Incidence 
(year) rates (per 100000) rates (per 100000) 
0-9 1175607 -* 154048 -* 
10-19 220918 - 236028 1.7 
20-29 131692 - 157238 5.18 
30-39 101533 3.95 111881 7.18 
40-49 75272 6.61 65608 6.69 
50-59 32150 - 49437 -
60-69 40686 - 21855 14.69 
70-79 18706 11.83 12523 37.19 
80-85+ 2996 - 4741 34.21 
-* : No cancer incidence 
in Finland and the USA.15 There is a striking 
increase in the female incidence rates, which 
are almost twice the incidence in male. Thy­
roid cancer incidence in Golestan province 
among both females and males in the year 2004 
continued to show a significant increase when 
compared with the years 1996-2000.15 
Analysis of our data by age-specific incidence 
shows that the highest rates were observed in 
the age of 70-79 years for females and males. 
Furthermore, age-specific analysis by 10-year 
age groups identified that thyroid cancer inci­
dence among young males and females in­
creased in the year 2004 (1.22/100000 for 
males and 2.65/100000 for females) when 
compared with the years 1996-2000 in Iran 
(0.62/ 100,000 for males and 1.59/100,000 for 
females).16 
There are several possible reasons for the in­
crease in thyroid cancer incidence. The only 
established risk factor for thyroid cancer in 
humans, besides age and gender, is ionizing 
radiation. Sex hormones, iodine deficiency and 
other factors have been suggested as risk fac­
tors for thyroid cancer, but the findings are 
inconsistent.17-21 The cause of this cancer is 
unknown. It seems that an environmental risk 
factor in Golestan province, such as radiation 
exposure or iodine supplementation, can 
explain the slow increase in thyroid cancer 
incidence. The findings from Cardis et al.,22 
however, suggest that diets deficient in stable 
iodine potentiate the risk of radiation-induced 
thyroid cancer and that continued use of di­
etary supplements containing potassium iodide 
substantially reduces the risk of radiation-in­
duced thyroid cancer, even if taken for many 
months or years after the exposure has 
occurred. 
Iran was considered as an endemic iodine 
deficient area until recently. Iodinization of 
salts had been started about seventeen years 
ago. A recent study from France suggest that 
evolution in clinical practice has been a major 
factor responsible for the increased thyroid can­
cer incidence.23 These include improvements in 
diagnostic practice, with increased use of more 
sophisticated diagnostic methods such as fine 
needle biopsy of the thyroid and radio-isotope 
thyroid scanning, change in monitoring of be­
nign thyroid problems, with broader indica­
tions for removal of solitary nodules, and the 
increase in ‘incidental’ diagnosis and the dis­
covery of less aggressive tumors. We believe 
that introduction and implementation of na­
tional evidence-based guidelines for the man­
agement of thyroid cancer should result in a 
greater improvement in survival. Additional 
research on the risk factors for thyroid cancer 
(Geographic, environmental and ethnic) is 
needed to explain the incidence of thyroid 
cancer. 
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Limitations of this study: This study however has 
some limitations as it is based just on one year 
data. As such further studies are needed to 
confirm these initial observations. 
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